Cargando…
Analgesic Effect of Electroacupuncture on Postherpetic Neuralgia: A Trial Protocol for a Multicenter Randomized Controlled Trial
INTRODUCTION: The chronic neuropathic pain associated with postherpetic neuralgia (PHN) can last for several months or even many years, seriously affecting the affected person’s work, sleep, mood, and daily life activities. In generaly, current treatments for PHN are at best limited and unsatisfacto...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586289/ https://www.ncbi.nlm.nih.gov/pubmed/34254233 http://dx.doi.org/10.1007/s40122-021-00283-8 |
_version_ | 1784597863688306688 |
---|---|
author | Liu, Qianyan Wu, Xiaoliang Guo, Jing Gao, Jie Liu, Bingyang Wang, Yuhang Xia, Minghui Pei, Lixia Sun, Jianhua |
author_facet | Liu, Qianyan Wu, Xiaoliang Guo, Jing Gao, Jie Liu, Bingyang Wang, Yuhang Xia, Minghui Pei, Lixia Sun, Jianhua |
author_sort | Liu, Qianyan |
collection | PubMed |
description | INTRODUCTION: The chronic neuropathic pain associated with postherpetic neuralgia (PHN) can last for several months or even many years, seriously affecting the affected person’s work, sleep, mood, and daily life activities. In generaly, current treatments for PHN are at best limited and unsatisfactory, and adverse reactions are common, especially in elderly patients. Electroacupuncture (EA) is widely used clinically to manage painful diseases, but there remains a lack of evidence to support the effectiveness of EA on PHN. This study is designed to assess the efficacy and safety of EA on PHN, and to provide evidence-based medical evidence for EA treatment of PHN. METHODS: This multicenter, prospective, randomized controlled trial will recruit 448 patients with PHN at seven clinical centers. Multicenter stratified variable block randomization will be used, and the eligible patients will be randomly allocated in a ratio of 1:1 to the EA group or sham EA group. The EA group will receive 4 weeks of EA treatment, given as 30-min treatment sessions, once daily, 5 times per week, for a total of 20 treatments; the sham EA group will receive sham EA treatment under the same conditions. PLANNED OUTCOMES: The primary outcome measure is the 11-point Numeric Rating Scale pain score at week 4. The secondary outcome measures, including mechanical pain threshold, pain area of PHN, average number of pain episodes, the short-form McGill Pain Questionnaire 2, Zoster Brief Pain Inventory, the Depression, Anxiety, and Positive Outlook Scale, Patient Global Impression of Change, safety of EA, and use of concomitant medications, among others. The primary analysis of the outcomes will be the mixed-effect model with repeated measurement between groups on an intent-to-treat population. TRIAL REGISTRATION: Clinicaltrials.gov identifier: NCT04560361. Registered 23 September 2020 (https://clinicaltrials.gov/ct2/show/NCT04560361?term=NCT04560361&draw=2&rank=1). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40122-021-00283-8. |
format | Online Article Text |
id | pubmed-8586289 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-85862892021-11-23 Analgesic Effect of Electroacupuncture on Postherpetic Neuralgia: A Trial Protocol for a Multicenter Randomized Controlled Trial Liu, Qianyan Wu, Xiaoliang Guo, Jing Gao, Jie Liu, Bingyang Wang, Yuhang Xia, Minghui Pei, Lixia Sun, Jianhua Pain Ther Study Protocol INTRODUCTION: The chronic neuropathic pain associated with postherpetic neuralgia (PHN) can last for several months or even many years, seriously affecting the affected person’s work, sleep, mood, and daily life activities. In generaly, current treatments for PHN are at best limited and unsatisfactory, and adverse reactions are common, especially in elderly patients. Electroacupuncture (EA) is widely used clinically to manage painful diseases, but there remains a lack of evidence to support the effectiveness of EA on PHN. This study is designed to assess the efficacy and safety of EA on PHN, and to provide evidence-based medical evidence for EA treatment of PHN. METHODS: This multicenter, prospective, randomized controlled trial will recruit 448 patients with PHN at seven clinical centers. Multicenter stratified variable block randomization will be used, and the eligible patients will be randomly allocated in a ratio of 1:1 to the EA group or sham EA group. The EA group will receive 4 weeks of EA treatment, given as 30-min treatment sessions, once daily, 5 times per week, for a total of 20 treatments; the sham EA group will receive sham EA treatment under the same conditions. PLANNED OUTCOMES: The primary outcome measure is the 11-point Numeric Rating Scale pain score at week 4. The secondary outcome measures, including mechanical pain threshold, pain area of PHN, average number of pain episodes, the short-form McGill Pain Questionnaire 2, Zoster Brief Pain Inventory, the Depression, Anxiety, and Positive Outlook Scale, Patient Global Impression of Change, safety of EA, and use of concomitant medications, among others. The primary analysis of the outcomes will be the mixed-effect model with repeated measurement between groups on an intent-to-treat population. TRIAL REGISTRATION: Clinicaltrials.gov identifier: NCT04560361. Registered 23 September 2020 (https://clinicaltrials.gov/ct2/show/NCT04560361?term=NCT04560361&draw=2&rank=1). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40122-021-00283-8. Springer Healthcare 2021-07-12 2021-12 /pmc/articles/PMC8586289/ /pubmed/34254233 http://dx.doi.org/10.1007/s40122-021-00283-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Study Protocol Liu, Qianyan Wu, Xiaoliang Guo, Jing Gao, Jie Liu, Bingyang Wang, Yuhang Xia, Minghui Pei, Lixia Sun, Jianhua Analgesic Effect of Electroacupuncture on Postherpetic Neuralgia: A Trial Protocol for a Multicenter Randomized Controlled Trial |
title | Analgesic Effect of Electroacupuncture on Postherpetic Neuralgia: A Trial Protocol for a Multicenter Randomized Controlled Trial |
title_full | Analgesic Effect of Electroacupuncture on Postherpetic Neuralgia: A Trial Protocol for a Multicenter Randomized Controlled Trial |
title_fullStr | Analgesic Effect of Electroacupuncture on Postherpetic Neuralgia: A Trial Protocol for a Multicenter Randomized Controlled Trial |
title_full_unstemmed | Analgesic Effect of Electroacupuncture on Postherpetic Neuralgia: A Trial Protocol for a Multicenter Randomized Controlled Trial |
title_short | Analgesic Effect of Electroacupuncture on Postherpetic Neuralgia: A Trial Protocol for a Multicenter Randomized Controlled Trial |
title_sort | analgesic effect of electroacupuncture on postherpetic neuralgia: a trial protocol for a multicenter randomized controlled trial |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586289/ https://www.ncbi.nlm.nih.gov/pubmed/34254233 http://dx.doi.org/10.1007/s40122-021-00283-8 |
work_keys_str_mv | AT liuqianyan analgesiceffectofelectroacupunctureonpostherpeticneuralgiaatrialprotocolforamulticenterrandomizedcontrolledtrial AT wuxiaoliang analgesiceffectofelectroacupunctureonpostherpeticneuralgiaatrialprotocolforamulticenterrandomizedcontrolledtrial AT guojing analgesiceffectofelectroacupunctureonpostherpeticneuralgiaatrialprotocolforamulticenterrandomizedcontrolledtrial AT gaojie analgesiceffectofelectroacupunctureonpostherpeticneuralgiaatrialprotocolforamulticenterrandomizedcontrolledtrial AT liubingyang analgesiceffectofelectroacupunctureonpostherpeticneuralgiaatrialprotocolforamulticenterrandomizedcontrolledtrial AT wangyuhang analgesiceffectofelectroacupunctureonpostherpeticneuralgiaatrialprotocolforamulticenterrandomizedcontrolledtrial AT xiaminghui analgesiceffectofelectroacupunctureonpostherpeticneuralgiaatrialprotocolforamulticenterrandomizedcontrolledtrial AT peilixia analgesiceffectofelectroacupunctureonpostherpeticneuralgiaatrialprotocolforamulticenterrandomizedcontrolledtrial AT sunjianhua analgesiceffectofelectroacupunctureonpostherpeticneuralgiaatrialprotocolforamulticenterrandomizedcontrolledtrial |